US Patent Issued to Medtronic Ireland Manufacturing UnLtd. on July 8 for "Systems and methods for assessing efficacy of renal neuromodulation therapy" (California, Minnesota Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,028, issued on July 8, was assigned to Medtronic Ireland Manufacturing UnLtd. Co. (Dublin).

"Systems and methods for assessing efficacy of renal neuromodulation therapy" was invented by Douglas Hettrick (Andover, Minn.) and Paul Coates (Corte Madera, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the target site with the neuromodulation...